Belleville S., Bherer L., Lepage M., Chertkow H., Gauthier S. (2008). Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment, Neuropsychologia.

Clement F., Belleville S., Gauthier S. (2008). Cognitive complaint in mild cognitive impairment and Alzheimer's disease, J Int Neuropsychol Soc, 14(2), 222-32.

Erkinjuntti T., Gauthier S., Bullock R., Kurz A., Hammond G., Schwalen S., Zhu Y., Brashear R. (2008). Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6), J Psychopharmacol.

Gauthier S. (2008). Editorial : clinical trials and aging section, J Nutr Health Aging, 12(3), 193.

Gauthier S. (2008). Editorial: The PLASA Study, J Nutr Health Aging, 12(4), 262.

Gauthier S. (2008). Symptomatic therapeutic aspects in Alzheimer's disease, Handb Clin Neurol, 89, 269-71.

Gauthier S., Dubois B., Feldman H., Scheltens P. (2008). Revised research diagnostic criteria for Alzheimer's disease, Lancet Neurol, 7(8), 668-70.

Gauthier S., Loft H., Cummings J. (2008). Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis, Int J Geriatr Psychiatry, 23(5), 537-545.

Gauthier S., Poirier J. (2008). Current and future management of Alzheimer's disease, Alzheimers Dement, 4(1 Suppl 1), S48-50.

Hsiung G. Y., Alipour S., Jacova C., Grand J., Gauthier S., Black S. E., Bouchard R. W., Kertesz A., Loy-English I., Hogan D. B., Rockwood K., Feldman H. H. (2008). Transition from Cognitively Impaired Not Demented to Alzheimer's Disease: An Analysis of Changes in Functional Abilities in a Dementia Clinic Cohort, Dement Geriatr Cogn Disord, 25(6), 483-490.

Hudon C., Belleville S., Gauthier S. (2008). The association between depressive and cognitive symptoms in amnestic mild cognitive impairment, Int Psychogeriatr, 1-14.

Khachaturian Z. S., Petersen R. C., Gauthier S., Buckholtz N., Corey-Bloom J. P., Evans B., Fillit H., Foster N., Greenberg B., Grundman M., Sano M., Simpkins J., Schneider L. S., Weiner M. W., Galasko D., Hyman B., Kuller L., Schenk D., Snyder S., Thomas R. G., Tuszynski M. H., Vellas B., Wurtman R. J., Snyder P. J., Frank R. A., Albert M., Doody R., Ferris S., Kaye J., Koo E., Morrison-Bogorad M., Reisberg B., Salmon D. P., Gilman S., Mohs R., Aisen P. S., Breitner J. C., Cummings J. L., Kawas C., Phelps C., Poirier J., Sabbagh M., Touchon J., Khachaturian A. S., Bain L. J. (2008). A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium, Alzheimers Dement, 4(3), 156-63.

Li H., Wetten S., Li L., St Jean P. L., Upmanyu R., Surh L., Hosford D., Barnes M. R., Briley J. D., Borrie M., Coletta N., Delisle R., Dhalla D., Ehm M. G., Feldman H. H., Fornazzari L., Gauthier S., Goodgame N., Guzman D., Hammond S., Hollingworth P., Hsiung G. Y., Johnson J., Kelly D. D., Keren R., Kertesz A., King S., Lovestone S., Loy-English I., Matthews P. M., Owen M. J., Plumpton M., Pryse-Phillips W., Prinjha R. K., Richardson J. C., Saunders A., Slater A. J., St George-Hyslop P. H., Stinnett S. W., Swartz J. E., Taylor R. L., Wherrett J., Williams S., Yarnall D. P., Gibson R. A., Irizarry M. C., Middleton L. T., Roses A. D. (2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease, Arch Neurol, 65(1), 45-53.

Peters K. R., Rockwood K., Black S. E., Hogan D. B., Gauthier S., Loy-English I., Hsiung G. Y., Jacova C., Kertesz A., Feldman H. H. (2008). Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals, Am J Geriatr Psychiatry, 16(2), 136-44.

Piton A., Michaud J. L., Peng H., Aradhya S., Gauthier S., Mottron L., Champagne N., Lafreniere R. G., Hamdan F. F., Joober R., Fombonne E., Marineau C., Cossette P., Dube M. P., Haghighi P., Drapeau P., Barker P. A., Carbonetto S., Rouleau G. A. (2008). Mutations in the calcium-related gene IL1RAPL1 are associated with autism, Hum Mol Genet.

Reisberg B., Gauthier S. (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease, Int Psychogeriatr, 20(1), 1-16.

Winblad B., Gauthier S., Scinto L., Feldman H., Wilcock G. K., Truyen L., Mayorga A. J., Wang D., Brashear H. R., Nye J. S. (2008). Safety and efficacy of galantamine in subjects with mild cognitive impairment, Neurology.